MindMed Closes $34.5 Million Financing, Cash Reserves Said To Be At $85 Million

Mind Medicine (NEO: MMED) has completed its previously announced bought deal private placement, raising gross proceeds of $34.5 million. The financing saw the exercise in full of the over-allotment option granted to underwriters.

The financing saw units of the company sold at a price of $1.90 each, resulting in the issuance of 18.2 million units of the company. Each unit contained one subordinate voting share and one half of a purchase warrant. Warrants are exercisable at a price of $2.45 until December 11, 2023, while also containing an acceleration clause.

Under the acceleration clause, if the company sees a daily weighted average trading price of its listed shares exceed $4.00 for a period of 10 days, the company can elect to force the warrant expiry date to 30 days upon granting notice of the acceleration. Warrants are also expected to be listed for trading under the symbol “MMED.WA” on the Neo Exchange.

The closing of the financing brings the total funds raised to date since its IPO to $121.4 million for the company. Approximately $85.0 million of that is said to remain in company coffers, with reserves to be used on the development of the digital medical division Albert along with continued development of its clinical trial pipeline. Funds from the latest financing are also to go towards additional microdosing research and development.

Mind Medicine last traded at $3.63 on the Neo.


Information for this briefing was found via Sedar and MindMed. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Steadright To Conduct Multi-Phased Exploration At Historic Goundafa Polymetallic Mine

Goliath Resources Drills 10.72 g/t Gold Over 7.83 Metres At Surebet

Related News

Proxy Fight Looms For MindMed Vs. Co-Founder

Mind Medicine’s (NASDAQ: MNMD) filed its preliminary proxy materials on Tuesday with the U.S. Securities and...

Wednesday, April 19, 2023, 09:43:00 AM

Mind Medicine Announces $50 Million Bought Deal Financing Days After Raising $34.5 Million

Mind Medicine (NEO: MMED) is raising even more cash. The company this evening announced that...

Monday, December 14, 2020, 08:43:58 PM

Mind Medicine Sees CEO Sell $24.7 Million In Company Stock

It appears that uplisting to the Nasdaq is good for business. Or, at least for...

Wednesday, May 26, 2021, 10:14:37 AM

Psychedelics: The Eight Capital Primer

Eight Capital recently produced a primer on the psychedelic sector saying that the companies are...

Monday, June 14, 2021, 03:38:00 PM

Mind Medicine: Canaccord Genuity Initiates Coverage With C$1.75 Price Target

Yesterday, Canaccord initiated coverage on Mind Medicine (NEO: MMED) with a Speculative Buy rating and...

Wednesday, September 16, 2020, 04:15:00 PM